HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erik E Karrer Selected Research

ASP2408

11/2016Immunosuppressive effect of ASP2408, a novel CD86-selective variant of CTLA4-Ig, in rats and cynomolgus monkeys.
9/2016Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of ASP2408, a Potent Selective T-Cell Costimulation Modulator After Single and Multiple Ascending Doses in Healthy Volunteers and RA Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Erik E Karrer Research Topics

Disease

3Rheumatoid Arthritis
11/2016 - 07/2016
1Inflammation (Inflammations)
11/2016
1Experimental Arthritis
11/2016

Drug/Important Bio-Agent (IBA)

2ASP2408IBA
11/2016 - 09/2016
2Proteins (Proteins, Gene)FDA Link
11/2016 - 09/2016
1Immunosuppressive Agents (Immunosuppressants)IBA
11/2016
1LigandsIBA
11/2016
1Abatacept (Orencia)FDA Link
11/2016
1Tetanus Toxoid (Vaccine, Tetanus)FDA Link
11/2016
1ASP2409IBA
07/2016
1Methotrexate (Mexate)FDA LinkGeneric
07/2016

Therapy/Procedure

1Kidney Transplantation
11/2016
1Therapeutics
07/2016